DOCSLIB.ORG

Skin Exam Codes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Skin Exam Codes Jan-07 Fernald Medical Monitoring Program Sort Code Physican Exam - Skin Exam codes Code Description 1 1100 edmea 2 1101 oily 3 1102 Warm 4 1103 Cool 5 1104 Rough 6 1105 smooth 7 1106 thick 8 3113 fragile 9 1107 Decreased mobility 10 1108 Decreased turgor 11 1109 Dehydration 12 3118 thin 13 3136 callous 14 1110 dry skin/xerosis 15 3142 ichthyasis (scaly skin) 16 3144 fissuring(cracking)of skin 17 3161 psoriasis 18 3108 chafing 19 1111 dandruff 20 1112 facial hirsutism 21 1113 atrophy 22 1114 keloid 23 3156 acrochordon 24 1115 acne 25 1116 skin tags 26 2000 Accessory Nipple 27 1117 scar due to surgery 28 1118 scar (undefined/unusual) 29 1119 scar due to trauma 30 31 1120 pale 32 1121 jaundiced; icteric 33 1123 reddish or ruddy complexion; flushing 34 3130 hyperpigmentation 35 1124 cyanotic (blue) 36 1125 fair complexion 37 1126 (brown) pigmented area, pigmented lesion 38 3157 age spots (liver spots, seile lentigines) Lentig 39 3176 darkening/discoloration/color variation 40 erythema due to skin grafts/ 1127 well healed skin grafts 41 1128 depigmented areas-vitiligo 42 1129 (multiple) freckles 43 3109 tanned skin 44 3114 sunburn 45 3185 peeling 46 47 1130 cherry angiomas 48 1131 spider angiomas 49 1132 purpura 50 1133 petechia 51 1134 ecchy,osis/brusie marks/contusion 52 3189 abrasion 53 54 3170 Skin graft 55 3169 radiation associated skin changes 56 3175 acanthosis nigricans 57 3180 (Facial skin) swelling 58 59 Skin - Continued 60 61 1135 venous star 62 1136 (multiple) varicosities 63 1137 venous lesion 64 1138 port wine location 65 1139 edematous 66 3107 rosacea 67 3127 spider veins 68 3128 capilliary fragility 69 3133 telangitis 70 3135 telangiactasia 71 area of skin reddended, inundated and 3138 most infected 72 3151 dilated capillaries 73 1158 erythematous 74 75 1140 undefined rash 76 1141 undefined lesion 77 1142 macule/macular rash 78 1143 patch 79 1144 papule/papular rash, lesion 80 3139 molluscum contagiosum 81 3177 fungal rash 82 3126 pimples 83 3160 lichen planus 84 3178 lichenification 85 3190 poison ivy 86 3152 insect bites 87 3145 cellulitis 88 89 1145 plaque 90 1146 nodule 91 1147 tumor 92 1148 wheal/urticaria/hives 93 1149 pruritic (scar) (bruritis) 94 3104 papilloma 95 3141 goose flesh 96 97 1150 vesion 98 1151 bulla 99 1152 pustule 100 1153 impetigo 101 1154 ulcer 102 1155 areas of elsatin breakdown 103 3112 excoriated lesions 104 1156 comedones/ blackheads 105 1157 eczema 106 3100 scabbed area, healing lesion 107 1159 keratosis 108 3145 cellulitis 109 110 3105 ganglion cyst 111 3106 retention cyst 112 1160 sebaceous cyst 113 114 3181 inclusion cyst 115 3182 subdermal cyst 116 2002 soft cyst 117 3183 pilonidal cyst 118 3191 furuncle, boil, carbuncle 119 120 1161 lipoma 121 122 3137 keratotic lesion/keratosis 123 1162 seborrheic keratosis 124 1163 actinic keratosis 125 1164 nevi(nevus) 126 1165 psoriatic rash or psoriasis 127 1166 senile keratosis 128 1167 cutaneous horn 129 1168 solar keratosis 130 1169 hyperkeratosis 131 132 1170 multiple moles 133 1171 single mole 134 135 1173 tinea; ringworm 136 137 1174 skiin cancer 138 3184 melanotic lesion 139 140 1175 (contact) dermatitis 141 142 1177 intertringo/ rash between folds of skin 143 1178 stsatis dermatitis 144 145 1179 (dry) seborrheic dermatitis 146 3134 exfoliate dermatitis 147 148 3103 candida rash/yeast infection rash/moniliasis 149 1180 athlete's foot/tinea pedis 150 1181 (diffuse) pedal onychomycosis 151 1182 inclusion of scap 152 153 3117 folliculitis 154 3108 perifollicular hermorrage 155 156 3150 dyshidrosis hermorrahage 157 158 1183 Hard, crusty, lesion 159 non pigmented, fibromatous lesion, 1184 dermatofibroma 160 3115 neuofibroma 161 162 1185 (pink) pearly raised lesion 163 1186 (dry) scaly lesion 164 1187 erythematous lesion 165 1188 excoriated lesion/excoriation 166 167 3116 yellow discolored lesion (xantheleome) 168 3119 dark lesion 169 3122 café au lait lesion 170 171 3138 split, broken, or cracked nails (brittle) 172 1189 hypertophic nails 173 1190 clubbed nails 174 1191 spoon nails 175 1172 Plummer's nails 176 1176 bleeding nails 177 1192 beau's lines 178 1193 paronychia 179 1194 splinter hemorrhages 180 3125 split nails 181 182 1195 (1st degree) burn 183 3141 acid burns 184 185 cholesterol deposits or 1196 xanthoma/xanthomatosis 186 1197 rheumatoid nodule 187 1199 Rhinophyma 188 189 3101 verruca wrinkles 190 3102 plantar wart 191 192 3110 facial wrinkles 193 3111 tatoo 194 3180 stretch marks (striae) 195 196 3120 scleroderma/ tight skin 197 3124 sun damage 198 3131 solar mottling 199 200 3132 (atropic) hair loss 201 1176 eyebrow thinning 202 1198 moderate facial hair/ excesive hair 203 3146 lighter turft of hair 204 205 3129 port-a-cathc in place 206 207 3140 inclusion spot 208 209 3119 shingles(HZV) 210 3121 herpes zoster (chicken pox) 211 212 Simean Crease 3187 (creasr on the palm of the hand) 213 3188 webbing 214 1122 scratch marks 215 3163 solar elastosis 216 3123 white lesion onlip 217 3179 irregularly pigmented lesion 218 3147 chronic venous stasis changes 219 220 221 3143 abnormal nail 222 3199 deformed nail 223 3158 infected nail 224 3162 patient did not undress 225 3192 bleeding nail 226 3193 accessory nipple 227 3194 soft cyst 228 3195 perifollicular hemorrhage 229 3196 shingles (hzv) 230 3197 split, broken or cracked nail 231 3198 acid burns 232 233 3148 Cold Sore (fever blister) 234 235 3153 Cyst, unspecified 236 3154 Hemosiderosis 237 3155 (Solar) elastosis 238 3159 Hemangioma 239 240 3164 (diffuse) fascitis 241 3165 Blister 242 3166 Animal Bite 243 3167 Male Hair Pattern(male patterned baldness) 244 3168 Tissue Mass nos 245 3169 Radaiation assoc skin changes 246 3170 Skin graft 247 3171 (Basal) skin cancer 248 249 3172 Abnormal skin exam/skin changes 250 3173 R/O (Basal) skin cancer 251 3174 laceration 252 3175 Acanthosis nigricans 253 3176 decreased skin healing(hard to heal) 254 3177 Pierced body part 255 3178 birthmark 256 257 3182 subdermal cyst 258 3183 pilonidal cysty 259 3186 Milia 260 261 3155 Fistula 262 263 3179 Irregular pigmented lesion 264.
Load more

Recommended publications
  • Differentiating Between Anxiety, Syncope & Anaphylaxis
    Differentiating between anxiety, syncope & anaphylaxis Dr. Réka Gustafson Medical Health Officer Vancouver Coastal Health Introduction Anaphylaxis is a rare but much feared side-effect of vaccination. Most vaccine providers will never see a case of true anaphylaxis due to vaccination, but need to be prepared to diagnose and respond to this medical emergency. Since anaphylaxis is so rare, most of us rely on guidelines to assist us in assessment and response. Due to the highly variable presentation, and absence of clinical trials, guidelines are by necessity often vague and very conservative. Guidelines are no substitute for good clinical judgment. Anaphylaxis Guidelines • “Anaphylaxis is a potentially life-threatening IgE mediated allergic reaction” – How many people die or have died from anaphylaxis after immunization? Can we predict who is likely to die from anaphylaxis? • “Anaphylaxis is one of the rarer events reported in the post-marketing surveillance” – How rare? Will I or my colleagues ever see a case? • “Changes develop over several minutes” – What is “several”? 1, 2, 10, 20 minutes? • “Even when there are mild symptoms initially, there is a potential for progression to a severe and even irreversible outcome” – Do I park my clinical judgment at the door? What do I look for in my clinical assessment? • “Fatalities during anaphylaxis usually result from delayed administration of epinephrine and from severe cardiac and respiratory complications. “ – What is delayed? How much time do I have? What is anaphylaxis? •an acute, potentially
    [Show full text]
  • Review Cutaneous Patterns Are Often the Only Clue to a a R T I C L E Complex Underlying Vascular Pathology
    pp11 - 46 ABstract Review Cutaneous patterns are often the only clue to a A R T I C L E complex underlying vascular pathology. Reticulate pattern is probably one of the most important DERMATOLOGICAL dermatological signs of venous or arterial pathology involving the cutaneous microvasculature and its MANIFESTATIONS OF VENOUS presence may be the only sign of an important underlying pathology. Vascular malformations such DISEASE. PART II: Reticulate as cutis marmorata congenita telangiectasia, benign forms of livedo reticularis, and sinister conditions eruptions such as Sneddon’s syndrome can all present with a reticulate eruption. The literature dealing with this KUROSH PARSI MBBS, MSc (Med), FACP, FACD subject is confusing and full of inaccuracies. Terms Departments of Dermatology, St. Vincent’s Hospital & such as livedo reticularis, livedo racemosa, cutis Sydney Children’s Hospital, Sydney, Australia marmorata and retiform purpura have all been used to describe the same or entirely different conditions. To our knowledge, there are no published systematic reviews of reticulate eruptions in the medical Introduction literature. he reticulate pattern is probably one of the most This article is the second in a series of papers important dermatological signs that signifies the describing the dermatological manifestations of involvement of the underlying vascular networks venous disease. Given the wide scope of phlebology T and its overlap with many other specialties, this review and the cutaneous vasculature. It is seen in benign forms was divided into multiple instalments. We dedicated of livedo reticularis and in more sinister conditions such this instalment to demystifying the reticulate as Sneddon’s syndrome. There is considerable confusion pattern.
    [Show full text]
  • Skin Manifestations of Illicit Drug Use Manifestações Cutâneas
    RevABDV81N4.qxd 12.08.06 13:10 Page 307 307 Educação Médica Continuada Manifestações cutâneas decorrentes do uso de drogas ilícitas Skin manifestations of illicit drug use Bernardo Gontijo 1 Flávia Vasques Bittencourt 2 Lívia Flávia Sebe Lourenço 3 Resumo: O uso e abuso de drogas ilícitas é um problema significativo e de abrangência mun- dial. A Organização das Nações Unidas estima que 5% da população mundial entre os 15 e 64 anos fazem uso de drogas pelo menos uma vez por ano (prevalência anual), sendo que meta- de destes usam regularmente, isto é, pelo menos uma vez por mês. Muitos dos eventos adver- sos das drogas ilícitas surgem na pele, o que torna fundamental que o dermatologista esteja familiarizado com essas alterações. Palavras-chave: Drogas ilícitas; Drogas ilícitas/história; Drogas ilícitas/efeitos adversos; Pele; Revisão Abstract: Illicit drug use and abuse is a major problem all over the world. The United Nations estimates that 5% of world population (aged 15-64 years) use illicit drugs at least once a year (annual prevalence) and half of them use drugs regularly, that is, at least once a month. Many adverse events of illicit drugs arise on the skin and therefore dermatologists should be aware of these changes. Keywords: Street drugs; Street drugs/history; Street drugs/adverse effects; Skin; Review HISTÓRICO Há mais de cinco mil anos na Mesopotâmia, minorar o sofrimento dos condenados. região onde hoje se situa o Iraque, os poderes cal- Provavelmente seja o ópio a droga nephente à qual mantes, soníferos e anestésicos do ópio (do latim Homero se referia como “o mais poderoso destrui- opium, através do grego opion, ‘seiva, suco’) já eram dor de mágoas”.1,2 conhecidos pelos sumérios.
    [Show full text]
  • Quick Tips on Recognizing Cutaneous Manifestations of Systemic Disease
    FEATURE ARTICLE 2.0 Quick Tips on Recognizing Contact Hours Cutaneous Manifestations of Systemic Disease Jennifer Cittadino ABSTRACT: Although many skin manifestations are isolated This article will concentrate on nonmalignant cutaneous to a dermatological disorder, some skin manifestations can manifestations of systemic disease. The body systems will berelatedtoadeeper,moresystemicissue.Theskinis be reviewed, and their associated skin manifestations will be related to other body systems and functions. The impor- discussed. Some of the skin manifestations can be seen in tance of being able to recognize these dermatological multiple systemic disorders, such as erythema nodosum, manifestations and associate them with potential systemic which can be seen in pulmonary disorders, collagen and disease can be a critical diagnostic tool for the practitioner. vascular disorders, and gastrointestinal disorders. Pictures Sometimes, these skin manifestations can be the first sign will be provided when possible. of an internal disease. Although challenging, recognition, prompt diagnosis, and treatment can alter the course of a CARDIOVASCULAR AND PULMONARY SYSTEM life-threatening illness. There are several general cutaneous signs of cardiovascular Key words: Cutaneous, Dermatology, Systemic, Skin disease that may commonly be seen. These findings may include edema, cyanosis, clubbing of the nails, and corneal he skin is the largest organ in the body and one arcus. The corneal arcus appears as a gray-white ring around of the most visible body systems. The skin has the cornea and correlates with age and cholesterol levels. a reciprocal relationship between what is visu- A diagonal earlobe crease is also reported to be a marker for alized on the surface and what is occurring coronary artery disease (Uliasz & Lebwohl, 2008).
    [Show full text]
  • (MPN) Symptoms
    RECOGNIZING SYMPTOMS RECOGNIZING YOUR MPN SYMPTOMS The MPN LANDMARK SURVEY* is a large-scale analysis of patients with myeloproliferative neoplasms (MPNs) and Healthcare Professionals (HCPs) who treat these rare, chronic blood cancers (813 patients; 457 hematologists/oncologists). The results from LANDMARK provide new information that validates previous findings about the effect of MPN symptoms and their impact on the lives of patients, even those with low-risk MPNs. Fatigue is a symptom of particular note. Across diseases it was reported as the most common and severe symptom, and the one that patients most wanted to resolve. Symptoms such as fatigue can be vague and challenging to quantify. It is difficult to measure tiredness and its impact on daily life. In addition to physical symptoms, patients in the survey reported emotional difficulties—feeling irritable, angry or depressed. Many patients surveyed suffered with their MPN symptoms for a year or more before diagnosis. LANDMARK helps to confirm that MPN symptoms have a significant, negative impact on daily activities and quality of life, often resulting in limited or canceled family and/or social activities. For some, it means having to miss days from work, reduce hours, or even leave their job. These issues create stress, anxiety, and financial hardship for MPN patients. This information is intended to help patients validate the impact of MPN symptoms and know that they are not alone. SYMPTOM RECOGNITION Patients in the survey often did not recognize the connection between certain symptoms they were experiencing and their MPN. For example, patients with MPNs often have difficulty sleeping; however, some patients who reported this symptom did not realize it was related to their MPN.
    [Show full text]
  • Pain Assessment and Treatment in Children with Significant Impairment of the Central Nervous System Julie Hauer, Amy J
    CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Pain Assessment and Treatment in Julie Hauer, MD, FAAP, a, b Amy J. Houtrow, MD, PhD, MPH, FAAP, c SECTION ON HOSPICE ChildrenAND PALLIATIVE MEDICINE, COUNCIL With ON CHILDREN Significant WITH DISABILITIES Impairment of the Central Nervous System Pain is a frequent and significant problem for children with impairment abstract of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment. Despite the significance of the problem, this population remains vulnerable to underrecognition and undertreatment of pain. Barriers to treatment may include uncertainty in identifying pain along with limited experience and fear with the use of aComplex Care Service, Division of General Pediatrics, Boston medications for pain treatment. Behavioral pain-assessment tools are Children’s Hospital, Assistant Professor, Harvard Medical School, Boston Massachusetts; bSeven Hills Pediatric Center, Groton, reviewed in this clinical report, along with other strategies for monitoring Massachusetts; and cDepartment of Physical Medicine and Rehabilitation, University of Pittsburgh, Pediatric Rehabilitation pain after an intervention. Sources of pain in this population include Medicine, Rehabilitation Institute, Children’s Hospital of Pittsburgh of acute-onset pain attributable to tissue injury or inflammation resulting UPMC, Pittsburgh, Pennsylvania in nociceptive pain, with pain then expected to resolve after treatment Dr Hauer conceptualized and drafted the initial manuscript, reviewed and responded to questions and comments from all reviewers, and directed at the source. Other sources can result in chronic intermittent pain contributed to writing the final manuscript; Dr Houtrow contributed that, for many, occurs on a weekly to daily basis, commonly attributed to to the initial drafting and editing at all stages, including the final manuscript; and all authors approved the final manuscript as gastroesophageal reflux, spasticity, and hip subluxation.
    [Show full text]
  • Carcinoid Syndrome
    Practice Clinical images Carcinoid syndrome Habib ur Rehman MBBS 72-year-old man was admitted to hospital with con- gestive heart failure, weight loss and chronic diar- A rhea. He had flushing of the face and cyanosis, and telangiectasia were present in the cheek area (Figure 1). A contrast-enhanced computed tomography scan of the liver showed multiple masses with ring enhancement that were compatible with metastases (Figure 2). An echocardio- gram showed right-sided dilation of the heart with severe tri- cuspid regurgitation. The patient’s aortic, mitral and pulmonic valves were normal in structure and function. A 24-hour urine collection showed a total output of 5-hydroxyindoleacetic acid of 1515 (normal 0–43) μmol/L. A biopsy of the liver with immunostaining for chromogranin and synaptophysin were strongly positive and confirmed a diagnosis of metasta- tic carcinoid syndrome. The patient died 4 months later. A carcinoid tumour is a rare neuroendocrinologic malig- nancy that commonly originates from enterochromaffin cells in the gastrointestinal tract. The rate of incidence of carcinoid tu- mours has increased from 1.09 cases per 100 000 in 1973 to 5.25 cases per 100 000 in 2004, with a median age at diagnosis of 63 years.1 This increase has likely resulted from improve- ments in the classification of such tumours and from more wide- spread use of certain diagnostic screening tools such as en- doscopy. Carcinoid syndrome occurs when cells from the tumour metastasize to the liver and vasoactive substances enter systemic circulation via the hepatic vein. Flushing involving the face and upper trunk are the most prominent cutaneous signs.
    [Show full text]
  • History & Physical Format
    History & Physical Format SUBJECTIVE (History) Identification name, address, tel.#, DOB, informant, referring provider CC (chief complaint) list of symptoms & duration. reason for seeking care HPI (history of present illness) - PQRST Provocative/palliative - precipitating/relieving Quality/quantity - character Region - location/radiation Severity - constant/intermittent Timing - onset/frequency/duration PMH (past medical /surgical history) general health, weight loss, hepatitis, rheumatic fever, mono, flu, arthritis, Ca, gout, asthma/COPD, pneumonia, thyroid dx, blood dyscrasias, ASCVD, HTN, UTIs, DM, seizures, operations, injuries, PUD/GERD, hospitalizations, psych hx Allergies Meds (Rx & OTC) SH (social history) birthplace, residence, education, occupation, marital status, ETOH, smoking, drugs, etc., sexual activity - MEN, WOMEN or BOTH CAGE Review Ever Feel Need to CUT DOWN Ever Felt ANNOYED by criticism of drinking Ever Had GUILTY Feelings Ever Taken Morning EYE OPENER FH (family history) age & cause of death of relatives' family diseases (CAD, CA, DM, psych) SUBJECTIVE (Review of Systems) skin, hair, nails - lesions, rashes, pruritis, changes in moles; change in distribution; lymph nodes - enlargement, pain bones , joints muscles - fractures, pain, stiffness, weakness, atrophy blood - anemia, bruising head - H/A, trauma, vertigo, syncope, seizures, memory eyes- visual loss, diplopia, trauma, inflammation glasses ears - deafness, tinnitis, discharge, pain nose - discharge, obstruction, epistaxis mouth - sores, gingival bleeding, teeth,
    [Show full text]
  • Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A
    “Cutaneous Manifestations of Disease” ACOI - Las Vegas FR Darrow, DO, MACOI Burrell College of Osteopathic Medicine This 56 year old man has a history of headaches, jaw claudication and recent onset of blindness in his left eye. Sed rate is 110. He has: A. Ergot poisoning. B. Cholesterol emboli. C. Temporal arteritis. D. Scleroderma. E. Mucormycosis. Varicella associated. GCA complex = Cranial arteritis; Aortic arch syndrome; Fever/wasting syndrome (FUO); Polymyalgia rheumatica. This patient missed his vaccine due at age: A. 45 B. 50 C. 55 D. 60 E. 65 He must see a (an): A. neurologist. B. opthalmologist. C. cardiologist. D. gastroenterologist. E. surgeon. Medscape This 60 y/o male patient would most likely have which of the following as a pathogen? A. Pseudomonas B. Group B streptococcus* C. Listeria D. Pneumococcus E. Staphylococcus epidermidis This skin condition, erysipelas, may rarely lead to septicemia, thrombophlebitis, septic arthritis, osteomyelitis, and endocarditis. Involves the lymphatics with scarring and chronic lymphedema. *more likely pyogenes/beta hemolytic Streptococcus This patient is susceptible to: A. psoriasis. B. rheumatic fever. C. vasculitis. D. Celiac disease E. membranoproliferative glomerulonephritis. Also susceptible to PSGN and scarlet fever and reactive arthritis. Culture if MRSA suspected. This patient has antithyroid antibodies. This is: • A. alopecia areata. • B. psoriasis. • C. tinea. • D. lichen planus. • E. syphilis. Search for Hashimoto’s or Addison’s or other B8, Q2, Q3, DRB1, DR3, DR4, DR8 diseases. This patient who works in the electronics industry presents with paresthesias, abdominal pain, fingernail changes, and the below findings. He may well have poisoning from : A. lead. B.
    [Show full text]
  • Carvedilol for the Treatment of Refractory Facial Flushing and Persistent Erythema of Rosacea
    THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; WILLIAM D. AUGHENBAUGH, MD ONLINE FIRST Carvedilol for the Treatment of Refractory Facial Flushing and Persistent Erythema of Rosacea Chia-Chi Hsu, MD; J. Yu-Yun Lee, MD; Department of Dermatology, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan Rosacea is a common facial disorder characterized by cen- trofacial erythema, flushing, telangiectasia, edema, pap- ules, pustules, ocular lesions, and rhinophyma in vari- ous combinations.1-4 The skin lesions most commonly affect the convex areas of the nose, cheeks, chin, and fore- head. Rosacea is classified as erythematotelangiectatic (ETR), papulopustular, and phymatous subtypes, and as ocular and granulomatous variants.2-4 The ETR subtype is typified by frequent episodes of facial flushing, telan- giectasias, and persistent centrofacial erythema and may be accompanied by facial edema, burning, or stinging. Severe flushing can cause significant physical discom- fort and emotional stress to the patients, and currently no satisfactory treatments are available. REPORT OF A CASE A48-year-oldwomanpresentedwithfacialflushingwith persistent erythema, and edema accompanied by burn- ing and itchy sensation that were provoked by various Figure 1. Severe erythematotelangiectatic rosacea before carvedilol stimuli, including heat, sun exposure, cold weather, stress, treatment. spicy food, alcohol, and cosmetics. She began to have fa- cial flushing and erythema about 11 years previously, shortly after glycolic acid treatments on the face. Since so many triggering or aggravating factors that she had then, she had visited many dermatology clinics for help, to avoid. She also experienced chronic insomnia and con- and despite treatments with doxycycline, fexofenadine stipation.
    [Show full text]
  • The Sudden Onset of Unilateral Flushing and Sweating
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.51.5.635 on 1 May 1988. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry 1988;51:635-642 Harlequin syndrome: the sudden onset of unilateral flushing and sweating JAMES W LANCE,* PETER D DRUMMOND,* SIMON C GANDEVIA,* JOHN G L MORRISt From the Departments ofNeurology, Prince Henry Hospital,* and Westmead Hospital,t Sydney, Australia SUMMARY Facial flushing and sweating were investigated in five patients who complained of the sudden onset of unilateral facial flushing in hot weather or when exercising vigorously. One patient probably suffered a brainstem infarct at the time that the unilateral flush was first noticed, and was left with a subtle Homer's syndrome on the side opposite to the flush. The other four had no other neurological symptoms and no ocular signs of Homer's syndrome. Thermal and emotional flushing and sweating were found to be impaired on the non-flushing side of the forehead in all five patients whereas gustatory sweating and flushing were increased on that side in four of the five patients, a combination of signs indicating a deficit of the second sympathetic neuron at the level of the third thoracic segment. CT and MRI of this area failed to disclose a structural lesion but latency from stimulation of the motor cortex and thoracic spinal cord to the third intercostal muscle was delayed Protected by copyright. on the non-flushing side in one patient. The complaint of unilateral flushing and sweating was abolished in one patient by ipsilateral stellate ganglionectomy. The unilateral facial flushing and sweating induced by heat in all five patients was thus a normal or excessive response by an intact sympathetic pathway, the other side failing to respond because of a sympathetic deficit.
    [Show full text]
  • Sex-Specific Mediation of Opioid-Induced Hyperalgesia by the Melanocortin-1 Receptor
    PAIN MEDICINE Anesthesiology 2010; 112:181–8 Copyright © 2009, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins Sex-specific Mediation of Opioid-induced Hyperalgesia by the Melanocortin-1 Receptor Aaron Juni, Ph.D.,* Minying Cai, Ph.D.,† Magda Stankova, Ph.D.,‡ Amanda R. Waxman, M.A.,§ Caroline Arout, M.A.,§ Gad Klein, Ph.D.,* Albert Dahan, M.D., Ph.D.,ʈ Victor J. Hruby, Ph.D.,† Jeffrey S. Mogil, Ph.D.# Benjamin Kest, Ph.D.** Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/112/1/181/248994/0000542-201001000-00031.pdf by guest on 23 September 2021 ABSTRACT only, increasing latencies by 72%, MSG606 increased latencies by Background: N-Methyl-D-aspartate receptor antagonists reverse approximately 60% exclusively in females. A lower morphine infusion Ϫ Ϫ hyperalgesia during morphine infusion in male mice only. Because dose (1.6 mg ⅐ kg 1 ⅐ 24 h 1) reduced baseline withdrawal latencies the melanocortin-1 receptor can act as a female-specific counter- by 45–52% in B6 and e/e mice of both sexes, which was reversed by part to N-methyl-D-aspartate receptors in ␬-opioid analgesic mech- MK-801, but not MSG606, in both male and female B6 mice. anisms, the authors assessed the contribution of melanocortin-1 Conclusions: The data indicate the sex-specific mediation of high- receptors to the sex-specific mechanisms underlying morphine hy- dose morphine-induced hyperalgesia by N-methyl-D-aspartate and peralgesia. melanocortin-1 receptors in male and female mice, respectively, Methods: The tail-withdrawal test was used to compare the noci- suggesting a broader relevance of this known sexual dimorphism.
    [Show full text]